Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations | Patent Publication Number 20230077039

US 20230077039 A1
Patent Number-
Application Number17887826
Filled DateAug 15, 2022
Priority DateAug 20, 2021
Publication DateMar 9, 2023
Original Assignee
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsRuth Milz
Steven Wang
Dean Najarian
Srihari Gopal
Panna Sanga
John Louie
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.